4 Articles
4 Articles
Amgen today announced plans to invest an additional $300 million in its manufacturing network in Puerto Rico, in order to further increase production capacity in the nation, improve state-of-the-art technologies, and ensure a reliable supply of medicines for patients.
Amgen adds $300M to Puerto Rico budget; Novartis to exit oral drug factory in Germany
Plus, news about FDA's one-day inspections and BioMADE: 🇵🇷 Amgen pours another $300M into Puerto Rico: The funds will be used to bolster its biologics production in Juncos, which was established ...
Amgen Announces $300 Million Investment in Juncos By Editor of Sin Comillas The pharmaceutical company Amgen (AMGN.O) announced on Monday a $300 Million investment in Puerto Rico to expand its production network, the company said in a press release. The investment will expand its biological product manufacturing plant in Juncos, which distributes drugs to more than 60 countries. This investment adds to the $650 Million investments that the pharm…
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium

